A randomized, phase II trial of cetuximab with or without...

Annals of Oncology 2015 / 03 Vol. 26; Iss. 3

A randomized, phase II trial of cetuximab with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer

Jimeno, A., Shirai, K., Choi, M., Laskin, J., Kochenderfer, M., Spira, A., Cline-Burkhardt, V., Winquist, E., Hausman, D., Walker, L., Cohen, R. B.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu574
Date:
March, 2015
File:
PDF, 152 KB
english, 2015
Conversion to is in progress
Conversion to is failed